Decreased miR-122 levels have been associated with poor prognosis and metastasis of hepatocellular carcinomas, and several targets of miR-122 have been implicated in tumorigenesis, including ADAM10, cyclin G1, SRF, Wnt1 and IGF1R [20]. This evidence concerns the gene SRF and hepatocellular carcinoma.